By Alan Mozes
TUESDAY, June 23, 2020 (HealthDay Information)
Could a cancer drug spare clinic sufferers from the ravages of severe COVID-19?
Yale physicians assume it can following giving the medicine, recognised as tocilizumab, to seriously ill sufferers again in March.
How does tocilizumab work? It has a extensive history of dampening the lifestyle-threatening immune method reactions cancer sufferers usually expertise whilst going through cure. Considering the fact that the exact same variety of hazardous reaction develops in several COVID-19 situations, the scientists imagined the drug may well make a variation for the sickest sufferers.
The end result